In that vein, NADPH oxidases (NOXs) have been associated with type 2 diabetes mellitus and its cardiovascular and metabolic implications, such as cardiomyopathy, hypertension, atherosclerosis, various stages of liver diseases, and nephropathy [14,15,16,17]. Here, FMO5 is linked to diabetes mellitus.